This research article focuses on the results of four rounds of mass drug administration (MDA) for cross-border districts of Côte d’Ivoire where lymphatic filariasis
In order to confirm that transmission recrudescence or importation does not occur for lymphatic filariasis (LF) after mass drug administration (MDA), the WHO recommends
This research article examines the Ov16 (onchocerciasis) and Wb123 (lymphatic filariasis) seroprevalence in the Bakoye and Falémé foci in Mali after 24 – 25
This short film covers the movement to eliminate Onchocerciasis (river blindness) in Cameroon, Africa. Follow our Vimeo account for more video footage from the
This editorial from Darin S. Evans raises important questions regarding the decision to stop mass drug administration (MDA) for countries with onchocerciasis as they
This research paper focuses on the first stop-Mass Drug Administration (MDA) decision for onchocerciasis in Nigeria. These findings can be modeled by other African
This research paper details the coordinated stop of MDA, decided by Sudan and Ethiopia, due to satisfying the World Health Organization’s criteria for interruption
This is a short video highlighting the importance of getting rid of onchocerciasis (river blindness). Follow our Vimeo account for more video footage from
Progress report on the elimination of human onchocerciasis, 2018–2019. Weekly Epidemiological Record. WHO, 2019. Overview November 8, 2019 Onchocerciasis is a parasitic infection caused
Progress report on the elimination of human onchocerciasis, 2017–2018. Weekly Epidemiological Record. WHO, 2018 Overview Onchocerciasis, commonly known as “river blindness”, is a parasitic
The World Health Organization (WHO) is developing a toolkit to help programs implement MMDP services. The toolkit incorporates relevant resources developed by WHO and
WHO provides orientation webinars (with Joint Application packages provided in English, French, and Spanish versions at this link) for national program managers and partners
